(Q67837683)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1780685%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Comparison of tumor-associated trypsin inhibitor (TATI) with CA125 as a marker for diagnosis and monitoring of epithelial ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1780685%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Comparison of Tumor-Associated Trypsin Inhibitor (Tati) with Ca125 as a Marker for Diagnosis and Monitoring of Epithelial Ovarian Cancer (English)

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

21 November 2022

1 reference

1

A. Gadducci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1780685

21 November 2022

author name string

M. Ferdeghini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1780685

21 November 2022

G. Rispoli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1780685

21 November 2022

C. Prontera

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1780685

21 November 2022

R. Bianchi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1780685

21 November 2022

P. Fioretti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1780685

21 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1780685

21 November 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1780685%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

http://www.tandfonline.com/doi/pdf/10.3109/00365519109104621

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

The Scandinavian journal of clinical & laboratory investigation. Supplementum

21 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1780685%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1780685%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

19-24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1780685%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

cites work

Ovarian tumor antigens

2

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

Reactivity of a monoclonal antibody with human ovarian carcinoma

21 November 2022

5

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

21 November 2022

6

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.

21 November 2022

8

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen

21 November 2022

11

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma

21 November 2022

12

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix

21 November 2022

13

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

Immunochemical demonstration of an ovarian cancer-associated urinary peptide

21 November 2022

14

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

Excretion of a tumor-associated trypsin inhibitor (TATI) in urine of patients with gynecological malignancy

21 November 2022

16

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

Tumour-associated trypsin inhibitor, TATI, in patients with pancreatic cancer, pancreatitis and benign biliary diseases

21 November 2022

19

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

Tumour-associated trypsin inhibitor (TATI) in ovarian cancer

21 November 2022

20

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma

21 November 2022

21

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

Immunohistochemical localization of CA 125 antigen in formalin-fixed paraffin sections of ovarian tumors with the use of Pronase

21 November 2022

22

1 reference

https://api.crossref.org/works/10.3109/00365519109104621

21 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1780685

21 November 2022

1 reference